Nurix Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Nurix Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2021 to Q4 2023.
  • Nurix Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending November 30, 2023 was $11.8M, a 2652% increase year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $11.8M +$11.4M +2652% Nov 30, 2023 10-K 2024-02-15
Q4 2022 $430K -$307K -41.7% Nov 30, 2022 10-K 2023-02-09
Q3 2022 $525K Aug 31, 2022 10-Q 2022-10-06
Q2 2022 $630K May 31, 2022 10-Q 2022-07-07
Q1 2022 $744K Feb 28, 2022 10-Q 2022-04-08
Q4 2021 $737K Nov 30, 2021 10-K 2022-01-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.